To provide faster access to safer and more effective drugs, medical devices, and cellular and tissue-based products, PMDA has endeavored to implement various measures to expedite and improve product reviews, such as by increasing the number of reviewers, expanding and improving consultations, and establishing the system of advanced review and consultation with electronic data.